320 completed, 71 recruiting, 49 not yet recruiting, 26 unknown. 174 Not applicable, 76 Phase 2, 75 Phase 3, 42 Phase 4, 41 Phase 1.
Follow Chronic Obstructive Pulmonary Disease (COPD): new trials by email Literature Review of Chronic Obstructive Pulmonary Disease (COPD) trials Research Report on Chronic Obstructive Pulmonary Disease (COPD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| cfMSC Stem Cell Therapy Targeting COPD clonal fetal MSCs - Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-30 | 2026-08-27 |
| Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD Urolithin A, Placebo - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Not yet recruiting | Bryan A. Ross | 198 | 2026-11-01 | 2026-10-13 |
| A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease RO7830698, Placebo - Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants | Phase 1 / Phase 2 | Recruiting | Hoffmann-La Roche | 104 | 2026-10-20 | 2026-10-20 |
| COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease Routine Clinical Care - Chronic Obstructive Pulmonary Disease (COPD), Severe Asthma | Not yet recruiting | VASCage GmbH | 350 | 2026-10-15 | 2026-10-09 | |
| Indoor Overheating and Physiological Strain in Older Adults With COPD Simulated indoor thermal environment - Chronic Obstructive Pulmonary Disease (COPD), Heat Stress | Not applicable | Not yet recruiting | University of Ottawa | 18 | 2026-10-13 | 2026-10-05 |
| Investigation of the Effect of Structured Energy Conservation Techniques Training on COPD Patients Structured Energy Conservation Techniques Training - Chronic Obstructive Pulmonary Disease (COPD) | Not applicable | Not yet recruiting | Akdeniz University | 70 | 2026-10-10 | 2026-08-12 |
| This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization dupilumab, Placebo - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Recruiting | Regeneron Pharmaceuticals | 754 | 2026-10-06 | 2026-10-16 |
| Primary Palliative Care - a Feasibility Cluster Trial Primary Palliative Care Complex Intervention (PrimPal) - Palliative Care, Primary Palliative Care | Not applicable | Not yet recruiting | University of Coimbra | 30 | 2026-10-01 | 2026-08-03 |
| Nutritional Risk and Diaphragmatic Thickness in Mechanically Ventilated COPD Patients Chronic Obstructive Pulmonary Disease (COPD), Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Not yet recruiting | Assiut University | 120 | 2026-10-01 | 2026-08-26 | |
| Multi-Omics Study of COPD Stages and Traditional Chinese Medicine Syndromes Chronic Obstructive Pulmonary Disease (COPD), Traditional Chinese Medicine Syndrome | Not yet recruiting | Guangzhou Institute of Respiratory Disease | 400 | 2026-10-01 | 2026-10-14 | |
| Improving Medication Management in COPD Pharmacist-led Medication Management Intervention - Chronic Obstructive Pulmonary Disease (COPD) | Not applicable | Not yet recruiting | Duke University | 92 | 2026-10-01 | 2026-08-26 |
| PBMT Associated With a Pulmonary Rehabilitation Program on the Functional Capacity of Patients With COPD Intervention Group, control group - Chronic Obstructive Pulmonary Disease (COPD) | Not applicable | Recruiting | Federal University of Health Science of Porto Alegre | 20 | 2026-10-01 | 2026-10-16 |
| Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High Flow: An MRI Study Nasal High Flow, Continuous Positive Airway Pressure - Chronic Obstructive Pulmonary Disease (COPD) | Not yet recruiting | Klinikum Dortmund Wirbelsäulenchirurgie | 20 | 2026-10-01 | 2026-10-21 | |
| BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA Chronic Obstructive Pulmonary Disease (COPD), Asthma | Recruiting | AstraZeneca | 600 | 2026-09-17 | 2026-09-23 | |
| Evaluation of the Benefits of Hypnosis in Improving the Quality of Life of Patients With Chronic Obstructive Pulmonary Disease (COPD) Suffering From Persistent Dyspnea Hypnosis, standardized telephone calls - Chronic Obstructive Pulmonary Disease (COPD), Dyspnea | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 154 | 2026-09-01 | 2026-06-10 |
| FITME Study: Formulating Individualised Exercise Prescription in Chronic Obstructive Pulmonary Disease Pulmonary rehabilitation programme - Chronic Obstructive Pulmonary Disease (COPD) | Not applicable | Not yet recruiting | Aveiro University | 46 | 2026-09-01 | 2026-09-01 |
| New Diagnostic Approaches in the Management of Inflammatory Lung Diseases Integrated Precision Medicine Platform - Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis | Not applicable | Not yet recruiting | Fondazione Don Carlo Gnocchi ETS | 200 | 2026-09-01 | 2026-07-23 |
| Cross-Regional Unmanned Aircraft Transport of Donor Lungs Cross-Regional Unmanned Aircraft Transport of Donor Lungs - Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD) | Not applicable | Not yet recruiting | The First Affiliated Hospital of Guangzhou Medical University | 25 | 2026-09-01 | 2026-08-27 |
| Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations Metformin - Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Not yet recruiting | Duke University | 45 | 2026-09-01 | 2026-04-29 |
| Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD No intervention - Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Rehabilitation | Not yet recruiting | ADIR Association | 50 | 2026-09-01 | 2026-08-10 |
Showing 20 of 518. Sign in to see all of them.
Pulmonary Disease, Chronic Obstructive (518) · Asthma (45) · Emphysema (30) · Bronchitis, Chronic (18) · Motor Activity (18) · Heart Failure (15) · Dyspnea (13) · Diabetes Mellitus (12) · Bronchitis (10) · Cardiovascular Diseases (10) · Disease (9) · Lung Diseases (9) · Bronchiectasis (8) · Neoplasms (8) · Respiratory Insufficiency (8)
Disease Attributes (518) · Pathological Conditions, Signs and Symptoms (518) · Pathologic Processes (517) · Chronic Disease (516) · Lung Diseases, Obstructive (516) · Respiratory Tract Diseases (516) · Lung Diseases (509) · Bronchial Diseases (76) · Immune System Diseases (56) · Hypersensitivity (46) · Hypersensitivity, Immediate (45) · Respiratory Hypersensitivity (45) · Behavior (43) · Signs and Symptoms (42) · Infections (39)
indacaterol (23) · Formoterol Fumarate (21) · Tiotropium Bromide (20) · Glycopyrrolate (16) · aclidinium bromide (13) · indacaterol-glycopyrronium combination (12) · Budesonide (10) · Salmeterol Xinafoate (9) · Roflumilast (7) · Noninvasive Ventilation (6) · Beclomethasone (5) · Budesonide, Formoterol Fumarate Drug Combination (5) · Exercise (5) · Fluticasone-Salmeterol Drug Combination (5) · revefenacin (5)
AstraZeneca (61) · Novartis Pharmaceuticals (25) · Weill Medical College of Cornell University (11) · Chiesi Farmaceutici S.p.A. (9) · University of Zurich (7) · Novartis (6) · ADIR Association (5) · Mylan Inc. (5) · Zhujiang Hospital (5) · Aveiro University (4) · Duke University (4) · Haisco Pharmaceutical Group Co., Ltd. (4) · Imperial College London (4) · Intech Biopharm Ltd. (4) · University of Alberta (4)
United States (118) · Germany (64) · United Kingdom (62) · France (51) · China (49) · Canada (48) · Spain (44) · Italy (34) · Netherlands (34) · Turkey (Türkiye) (34) · Denmark (33) · Hungary (30) · Poland (29) · Belgium (26) · Bulgaria (22)
Esther Garcia, MD (8) · Konrad E Bloch, MD (7) · Dave Singh, MD (4) · Esther Garcia, Ph.D. (4) · Talant M Sooronbaev, MD (4) · Tristan Bonnevie, PhD (4) · Xin Chen, Doctor (4) · Fernando J Martinez, MD, MS (3) · John R Hurst, PhD FRCP (3) · Alda S Marques, PhD (2) · Alda S. Marques, PhD (2)
PMID 42476723, PMID 20102307, PMID 42551404, PMID 19716960, PMID 21518460, PMID 22334770, PMID 22544891, PMID 23117188, PMID 24120253, PMID 25044280, PMID 27462120, PMID 28074135, PMID 28419462, PMID 28487349, PMID 31539467, PMID 32393215, PMID 33124005, PMID 34495549, PMID 35815359, PMID 36681255, PMID 42708515, PMID 7651472, PMID 10430726, PMID 10992531, PMID 11316667, PMID 11401887, PMID 11491153, PMID 11549531, PMID 12204862, PMID 12570114, PMID 12894005, PMID 13251968, PMID 15332404, PMID 15591470, PMID 15764761, PMID 16055882, PMID 16135736, PMID 16157462, PMID 16203030, PMID 16357111, PMID 16387937, PMID 16777998, PMID 16844726, PMID 17185492, PMID 17255565, PMID 17505694, PMID 17507545, PMID 17530528, PMID 17684223, PMID 17690147
2017 (3), R01HL136682 (3), 2005 (2), 2014 (2), 2015 (2), 2019 (2), 2023 (2), 2025 (2), R01HL131960 (2), R44HL172444 (2), 1UM1HL113115-01A1 (1), 2008 (1), 2009 (1), 2016 (1), 2018 (1)